Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 3;38(47):7440-7444.
doi: 10.1016/j.vaccine.2020.09.082. Epub 2020 Oct 10.

Diarrhea hospitalization costs among children <5 years old in Madagascar

Affiliations

Diarrhea hospitalization costs among children <5 years old in Madagascar

Eleanor Burnett et al. Vaccine. .

Abstract

Background: Following a recommendation by the World Health Organization, Madagascar introduced rotavirus vaccine in 2014. Though national rotavirus vaccine coverage has remained <80%, rotavirus hospitalizations declined by 78%. Gavi, the Vaccine Alliance, has provided financial support for rotavirus vaccine, however the Malagasy government has increasing responsibility for the financial cost.

Methods: In this evaluation, we describe the direct medical, direct non-medical, and indirect cost of illness due to diarrhea among children <5 years old at a public pediatric referral hospital. A 3-part structured questionnaire was administered during and following the hospitalization and the child's hospital record was reviewed.

Results: In total, 96 children were included in this analysis. The median total cost of the illness was $156.00 (IQR: 104.00, 210.86) and the median direct medical cost was $107.22. Service delivery costs represented a median of 44% of the inpatient costs; medications and diagnostic tests represented a median of 28% and 20% of the total costs of the hospitalization, respectively. The median percentage of the total illness costs paid by the household was 67%. Among households with income of <$61/month, the median costs of the illness paid by the household were $78.55, representing a median of 168% of the household's monthly expenses. Among households earning >$303/month, the median costs paid by the household were $147.30, representing a median of 53% of the household's monthly expenses. Among all household income levels, caregivers commonly paid these bills from savings, borrowed money, and donations.

Conclusions: Our findings will be useful in assessing the cost-effectiveness of rotavirus vaccine by decisionmakers. These results may also help hospital administrators and healthcare providers better understand the financial constraints of families.

Keywords: Diarrhea; Madagascar; Rotavirus.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.
Median and interquartile range of the total cost, direct medical costs, direct non-medial costs, and indirect costs of diarrhea illness resulting in hospitalization among children <5 years old in Madagascar in US dollars.
Figure 2.
Figure 2.
Total cost of a diarrhea illness resulting in hospitalization among children <5 years old in Madagascar paid by the child’s household and as a proportion of the household’s monthly expenditures by monthly income category.

References

    1. Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Rev Vaccines. 2017;16(10):987–95. Epub 2017/08/24. doi: 10.1080/14760584.2017.1371595. - DOI - PMC - PubMed
    1. WHO. Rotavirus Vaccines WHO Position Paper. Weekly Epidemiological Record. 2013;88(5):49–64. Epub 1 February 2013. - PubMed
    1. WHO-UNICEF estimates of rotavirus vaccine coverage. http://www.who.int/immunization/monitoring_surveillance/routine/coverage... 2017.
    1. Rahajamanana VL, Raboba JL, Rakotozanany A, Razafindraibe NJ, Andriatahirintsoa E, Razafindrakoto AC, et al. Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar. Vaccine. 2018;36(47):7198–204. Epub 2017/09/30. doi: 10.1016/j.vaccine.2017.08.091. - DOI - PMC - PubMed
    1. Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030. Vaccine. 2012;30 Suppl 1:A7–14. Epub 2012/05/02. doi: 10.1016/j.vaccine.2011.12.096. - DOI - PMC - PubMed

Publication types

Substances